Dexcom | DXCM

Stock Price
138.02
Daily Change
0.04 0.03%
Monthly
-1.37%
Yearly
10.48%
Q2 Forecast
136.05
Peers Price Chg Day Year Date
ABT Abbott 106.90 -0.06 -0.06% -1.70% Apr/25
ALGN Align Technology 310.47 -4.11 -1.31% -12.43% Apr/25
ATRC AtriCure 22.61 -0.41 -1.78% -46.49% Apr/25
AVNS Avanos Medical 17.85 -0.86 -4.60% -39.06% Apr/25
BAX Baxter International 40.25 -0.73 -1.78% -12.65% Apr/25
BDX Becton, Dickinson and Co. 230.77 -3.18 -1.36% -10.73% Apr/25
BSX Boston Scientific 73.27 0.42 0.58% 43.39% Apr/25
COO Cooper Companies 89.90 -0.35 -0.38% -5.12% Apr/25
DXCM Dexcom 138.02 0.04 0.03% 10.48% Apr/25
EW Edwards Lifesciences 87.89 -0.84 -0.94% 0.54% Apr/25
GMED Globus Medical 50.37 -1.07 -2.08% -12.64% Apr/25
HOLX Hologic 75.71 -1.07 -1.39% -10.84% Apr/25
IART Integra LifeSciences 28.43 -0.95 -3.23% -47.55% Apr/25
JNJ J&J 146.84 -1.73 -1.16% -9.70% Apr/25
MASI Masimo 135.35 -0.57 -0.42% -27.59% Apr/25
MDT Medtronic 79.06 -1.21 -1.50% -12.13% Apr/25
MMSI Merit Medical Systems 73.39 -0.64 -0.86% -5.51% Apr/25
PODD Insulet 164.03 -3.20 -1.91% -48.20% Apr/25
ROG Roche Holding 219.45 0.65 0.30% -20.55% Apr/26
SYK Stryker 336.85 -0.45 -0.13% 12.73% Apr/25
TFX Teleflex 206.12 -5.36 -2.53% -23.19% Apr/25
TNDM Tandem Diabetes Care 35.56 0.44 1.25% -5.17% Apr/25
WST West Pharmaceutical Services 368.66 -17.78 -4.60% 3.20% Apr/25
ZBH Zimmer Biomet Holdings 119.52 -1.64 -1.35% -14.06% Apr/25

Indexes Price Day Year Date
CCMP USND 15612 -100.99 -0.64% 31.70% Apr/25
RTY US2000 1981 -14.31 -0.72% 13.13% Apr/26
SPX US500 5083 -23.21 -0.46% 22.90% Apr/26
NDX US100 17430 -96.30 -0.55% 36.11% Apr/25
US100 US100 17597 -96.30 -0.55% 33.72% Apr/26

Dexcom traded at $138.02 this Thursday April 25th, increasing $0.04 or 0.03 percent since the previous trading session. Looking back, over the last four weeks, Dexcom gained 1.37 percent. Over the last 12 months, its price rose by 10.48 percent. Looking ahead, we forecast Dexcom to be priced at 136.05 by the end of this quarter and at 128.40 in one year, according to Trading Economics global macro models projections and analysts expectations.

Dexcom, Inc. is a medical device company. The Company is primarily focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems for use by people with diabetes and by healthcare providers. Its products include Dexcom G6 and Dexcom Share. The G6 is a CGM system that can be used as part of an integrated system with other compatible medical devices and electronic interfaces, which may include automated insulin dosing systems, insulin pumps, blood glucose meters or other electronic devices used for diabetes management. Its Dexcom Share remote monitoring system, offered for use with its Dexcom system, uses an app on the patient’s iPhone, iPod touch, iPad or Android mobile device to securely and wirelessly transmit glucose information to the cloud and then to apps on the mobile devices of up to five designated recipients, who can remotely monitor a patient’s glucose information and receive alert notifications.